Doctor of Philosophy, Case Western Reserve University, 2024, Biomedical Engineering
Ultrasound (US) is safe and low-cost relative to other imaging technologies, making it an increasingly popular diagnostic modality. US contrast is often limited by relatively low differences in acoustic impedance in the body, necessitating the use of contrast agents like microbubbles (MBs; ~1-10 µm diameter) which are intravenously injected and used to compensate for low contrast in conventional B-mode US imaging. The large size of MBs, however, limits their applications to the blood pool. In many diseases, including cancer, information beyond the blood pool is needed for diagnosis and staging. For instance, in many cancers (e.g. prostate, mammary, ovarian etc.), tumors are characterized by high vascular permeability and low lymphatic drainage, which increases the potential for enhanced permeability and retention (EPR) of macromolecules (~200 nm). When present, EPR leads to the tumor-localized accumulation of nano-agents. Nanobubbles (NBs) are new-age submicron bubble agents (100-500 nm diameter) capable of extravasation beyond the vascular network while providing enhanced US contrast similar to MBs.
Recently, our group showed that active targeting of NBs to prostate specific membrane antigen (PSMA) rapidly and selectively enhances tumor accumulation and retention. These processes were visualized in real-time with clinical US. This project established NBs as a sensitive detection tool in the diagnosis of PSMA-positive prostate cancer due to localized NB accumulation, reduced diameter and higher number density (NBs per volume) of NBs compared to MBs of similar composition. Together, these points enable: 1) contrast visualization of small capillaries with higher fidelity, and 2) imaging of extravascular cellular targets reached via extravasation of NBs in leaky blood vessels while employing 3) a safe and widely accessible imaging modality. Together, contrast enhanced ultrasound (CEUS) using NBs (NB-CEUS) is a detection method with high biocompatibility and high safe (open full item for complete abstract)
Committee: Agata Exner (Advisor); Dan Ma (Committee Chair); Douglas Martin (Committee Member); Geoffrey Vince (Committee Member); Anirban Sen Gupta (Committee Member)
Subjects: Acoustics; Biology; Biomedical Engineering; Biomedical Research; Biophysics; Engineering; Health; Health Sciences; Medical Imaging; Nanoscience; Nanotechnology; Oncology; Radiology; Scientific Imaging; Technology